66 records, the earliest from 28 May 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
66 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 13 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 29 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 13 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 11 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 29 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and Final dividend |
| 13 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
| 14 Nov 2024 | Financial Results/Dividend | To consider and approve the Standalone and Consolidated financial results for the period ended September 30, 2024 and Interim dividend |
| 30 Sep 2024 | Other business matters | To consider other business matters - Integration and consolidation ofthe generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC(wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (whollyowned subsidiary of Company s subsidiary) |
| 13 Aug 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
